SCHEMBL6345394

SCHEMBL6345394

CC(Cc1cccc(C(C)(C)C)c1)CN1CC(C)OC(C)C1

nearest known ligand 0.73

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SIGMAR1 Q99720 3/20 0.73
EBP Q15125 1/20 0.73
ADORA3 P0DMS8 1/20 0.61
CHRM1 P11229 1/20 0.61
DRD3 P35462 1/20 0.61
KCNH2 Q12809 1/20 0.61
ALDH1A1 P00352 4/20 0.41
L3MBTL1 Q9Y468 2/20 0.41
SMN1; SMN2 Q16637 1/20 0.41
MAPK1 P28482 2/20 0.38
KDM4E B2RXH2 3/20 0.37
HTT P42858 1/20 0.37
POLB P06746 1/20 0.37
HTR2A P28223 1/20 0.37
HTR2C P28335 1/20 0.37
HTR2B P41595 1/20 0.37
HSD17B10 Q99714 1/20 0.37
TDP1 Q9NUW8 1/20 0.36
CYP2A13 Q16696 1/20 0.36
GAA P10253 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Fenpropimorph SCHEMBL9164245 0.84 SIGMAR1 (1.00) SIGMAR1EBPADORA3CHRM1DRD3
Fenpropimorph SCHEMBL22363 0.84 SIGMAR1 (1.00) SIGMAR1EBPADORA3CHRM1DRD3
Fenpropimorph SCHEMBL12473532 0.84 SIGMAR1 (1.00) SIGMAR1EBPADORA3CHRM1DRD3
Fenpropimorph SCHEMBL29455102 0.84 SIGMAR1 (1.00) SIGMAR1EBPADORA3CHRM1DRD3
Fenpropimorph SCHEMBL9020991 0.84 SIGMAR1 (1.00) SIGMAR1EBPADORA3CHRM1DRD3
Fenpropimorph SCHEMBL30367069 0.84 SIGMAR1 (1.00) SIGMAR1EBPADORA3CHRM1DRD3
Fenpropimorph SCHEMBL7953741 0.84 SIGMAR1 (1.00) SIGMAR1EBPADORA3CHRM1DRD3
Fenpropimorph SCHEMBL22362 0.84 SIGMAR1 (1.00) SIGMAR1EBPADORA3CHRM1DRD3
Fenpropimorph SCHEMBL3710228 0.83 SIGMAR1 (0.97) SIGMAR1EBPADORA3CHRM1DRD3
Fenpropimorph SCHEMBL3710231 0.83 SIGMAR1 (0.97) SIGMAR1EBPADORA3CHRM1DRD3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050101783-A1 N-(heterocycle-methyl)alkylamine derivative, process for producing the same, and bactericide KUREHA CORPORATION (JP) 2005-05-12 US disclosed
US-20040152903-A1 6-chloro-3-pyridylmethylpropylamine derivatives, preparation process thereof and bactericides KUREHA CORPORATION (JP) 2004-08-05 US disclosed
US-6271385-B1 FUNGICIDES (SUCH AS THOSE FOR USE IN FARMING AND HORTICULTURE). KUREHA KAGAKU KOGYO KABUSHIKI KAISHA (JP) 2001-08-07 US disclosed
EP-1020441-A1 N-HETEROCYCLIC METHYLPROPYLAMINE DERIVATIVES, PROCESS FOR PRODUCING THE SAME AND GERMICIDES KUREHA KAGAKU KOGYO KABUSHIKI KAISHA (JP) 2000-07-19 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050101783-A1 N-(heterocycle-methyl)alkylamine derivative, process for producing the same, and bactericide HBZ, ACMSD, HDHD5 SIGMAR1 558/4885EBP 1298/4885ADORA3 1491/4885
US-20040152903-A1 6-chloro-3-pyridylmethylpropylamine derivatives, preparation process thereof and bactericides PGLS, TLR6, UROD SIGMAR1 3254/4885EBP 526/4885ADORA3 2266/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.